최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기IUBMB life, v.73 no.5, 2021년, pp.761 - 773
Varela‐Calviño, Rubén (Department of Biochemistry and Molecular Biology University of Santiago de Compostela Santiago de Compostela Spain) , Rodríguez‐Quiroga, Marta (Institute of Research in Health and Innovation Universidade do Porto Porto Portugal) , Dias Carvalho, Patrícia (Institute of Research in Health and Innovation Universidade do Porto Porto Portugal) , Martins, Flavia (Institute of Research in Health and Innovation Universidade do Porto Porto Portugal) , Serra‐Roma, André (Institute of Research in Health and Innovation Universidade do Porto Porto Portugal) , Vázquez‐Iglesias, Lorena (Department of Biochemistry Immunology and Genetics, University of Vigo Vigo Spain) , Páez de la Cadena, María (Department of Biochemistry Immunology and Genetics, University of Vigo Vigo Spain) , Velho, Sérgia (Institute of Research in Health and Innovation Universidade do Porto Porto Portugal) , Cordero, Oscar J. (Department of Biochemistry and Molecular Biology University of Santiago de Compostela Santiago de Compostela Spain)
AbstractThe cell membrane glycoprotein CD26 with peptidase activity (DPP4) and/or its soluble CD26/DPP4 counterpart expression and/or activity are altered in several cancers. Its role in metastasis development was recently highlighted by the discovery of CD26+ cancer stem cell subsets and the fact t...
Oskarsson, T., Batlle, E., Massague, J.. Metastatic Stem Cells: Sources, Niches, and Vital Pathways. Cell stem cell, vol.14, no.3, 306-321.
Beckenkamp, Aline, Davies, Samuel, Willig, Júlia Biz, Buffon, Andréia. DPPIV/CD26: a tumor suppressor or a marker of malignancy?. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, vol.37, no.6, 7059-7073.
Ghani, F.I., Yamazaki, H., Iwata, S., Okamoto, T., Aoe, K., Okabe, K., Mimura, Y., Fujimoto, N., Kishimoto, T., Yamada, T., Xu, C.W., Morimoto, C.. Identification of cancer stem cell markers in human malignant mesothelioma cells. Biochemical and biophysical research communications, vol.404, no.2, 735-742.
Herrmann, Harald, Sadovnik, Irina, Cerny-Reiterer, Sabine, Rülicke, Thomas, Stefanzl, Gabriele, Willmann, Michael, Hoermann, Gregor, Bilban, Martin, Blatt, Katharina, Herndlhofer, Susanne, Mayerhofer, Matthias, Streubel, Berthold, Sperr, Wolfgang R., Holyoake, Tessa L., Mannhalter, Christine, Valent, Peter. Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia. Blood, vol.123, no.25, 3951-3962.
CD26 a Cancer Stem Cell marker and therapeutic target. Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie, vol.71, 135-138.
Pang, Roberta, Law, Wai Lun, Chu, Andrew C.Y., Poon, Jensen T., Lam, Colin S.C., Chow, Ariel K.M., Ng, Lui, Cheung, Leonard W.H., Lan, Xiao R., Lan, Hui Y., Tan, Victoria P.Y., Yau, Thomas C., Poon, Ronnie T., Wong, Benjamin C.Y.. A Subpopulation of CD26+ Cancer Stem Cells with Metastatic Capacity in Human Colorectal Cancer. Cell stem cell, vol.6, no.6, 603-615.
Cheung, Alvin Ho-Kwan, Iyer, Deepak Narayanan, Lam, Colin Siu-Chi, Ng, Lui, Wong, Sunny K. M., Lee, Hung-Sing, Wan, Timothy, Man, Johnny, Chow, Ariel K. M., Poon, Ronnie T., Pang, Roberta, Law, Wai-Lun. Emergence of CD26+ Cancer Stem Cells with Metastatic Properties in Colorectal Carcinogenesis. International journal of molecular sciences, vol.18, no.6, 1106-.
LIETO, EVA, GALIZIA, GENNARO, ORDITURA, MICHELE, ROMANO, CIRO, ZAMBOLI, ANNA, CASTELLANO, PAOLO, MABILIA, ANDREA, AURICCHIO, ANNAMARIA, DE VITA, FERDINANDO, GEMEI, MARICA. CD26-positive/CD326-negative circulating cancer cells as prognostic markers for colorectal cancer recurrence. Oncology letters, vol.9, no.2, 542-550.
NISHIKAWA, SHIMPEI, KONNO, MASAMITSU, HAMABE, ATSUSHI, HASEGAWA, SHINICHIRO, KANO, YOSHIHIRO, FUKUSUMI, TAKAHITO, SATOH, TAROH, TAKIGUCHI, SHUJI, MORI, MASAKI, DOKI, YUICHIRO, ISHII, HIDESHI. Surgically resected human tumors reveal the biological significance of the gastric cancer stem cell markers CD44 and CD26. Oncology letters, vol.9, no.5, 2361-2367.
Vázquez-Iglesias, Lorena, Barcia-Castro, Leticia, Rodríguez-Quiroga, Marta, Páez de la Cadena, María, Rodríguez-Berrocal, Javier, Cordero, Oscar J.. Surface expression marker profile in colon cancer cell lines and sphere-derived cells suggests complexity in CD26+ cancer stem cells subsets. Biology open, vol.8, no.7, bio041673-bio041673.
Lam, Colin Siu-Chi, Cheung, Alvin Ho-Kwan, Wong, Sunny Kit-Man, Wan, Timothy Ming-Hun, Ng, Lui, Chow, Ariel Ka-Man, Cheng, Nathan Shiu-Man, Pak, Ryan Chung-Hei, Li, Hung-Sing, Man, Johnny Hon-Wai, Yau, Thomas Chung-Cheung, Lo, Oswens Siu-Hung, Poon, Jensen Tung-Chung, Pang, Roberta Wen-Chi, Law, Wai Lun. Prognostic Significance of CD26 in Patients with Colorectal Cancer. PloS one, vol.9, no.5, e98582-.
Larrinaga, Gorka, Perez, Itxaro, Sanz, Begoña, Beitia, Maider, Errarte, Peio, Fernández, Ainhoa, Blanco, Lorena, Etxezarraga, María C., Gil, Javier, López, José I.. Dipeptidyl-Peptidase IV Activity Is Correlated with Colorectal Cancer Prognosis. PloS one, vol.10, no.3, e0119436-.
Boonacker, Emil, Van Noorden, Cornelis J.F.. The multifunctional or moonlighting protein CD26/DPPIV. European journal of cell biology, vol.82, no.2, 53-73.
Gorrell, M. D., Gysbers, V., McCaughan, G. W.. CD26: A Multifunctional Integral Membrane and Secreted Protein of Activated Lymphocytes. Scandinavian journal of immunology, vol.54, no.3, 249-264.
Cordero, Oscar J., Salgado, Francisco J., Nogueira, Montserrat. On the origin of serum CD26 and its altered concentration in cancer patients. Cancer immunology, immunotherapy : CII, vol.58, no.11, 1723-1747.
Cancer Res Kajiyama H 2753 62 2002 Prolonged survival and decreased invasive activity attributable to dipeptidyl peptidase IV overexpression in ovarian carcinoma
Mizokami, Yayoi, Kajiyama, Hiroaki, Shibata, Kiyosumi, Ino, Kazuhiko, Kikkawa, Fumitaka, Mizutani, Shigehiko. Stromal cell-derived factor-1α-induced cell proliferation and its possible regulation by CD26/dipeptidyl peptidase IV in endometrial adenocarcinoma. International journal of cancer: Journal international du cancer, vol.110, no.5, 652-659.
Wesley, Umadevi V., Albino, Anthony P., Tiwari, Shakuntala, Houghton, Alan N.. A Role for Dipeptidyl Peptidase IV in Suppressing the Malignant Phenotype of Melanocytic Cells. The Journal of experimental medicine, vol.190, no.3, 311-322.
Wesley, Umadevi V., Tiwari, Shakuntala, Houghton, Alan N.. Role for dipeptidyl peptidase IV in tumor suppression of human non small cell lung carcinoma cells. International journal of cancer: Journal international du cancer, vol.109, no.6, 855-866.
Lu, Congyi, Tilan, Jason U., Everhart, Lindsay, Czarnecka, Magdalena, Soldin, Steven J., Mendu, Damodara R., Jeha, Dima, Hanafy, Jailan, Lee, Christina K., Sun, Junfeng, Izycka-Swieszewska, Ewa, Toretsky, Jeffrey A., Kitlinska, Joanna. Dipeptidyl Peptidases as Survival Factors in Ewing Sarcoma Family of Tumors. The Journal of biological chemistry, vol.286, no.31, 27494-27505.
Cancer Res Ten Kate J 4688 44 1984 Quantitative changes in adenosine deaminase isoenzymes in human colorectal adenocarcinomas
Kate, Joop Ten, van de Ingh, Harry F. G. M., Khan, P. Meera, Bosman, Fré T.. Adenosine deaminase complexing protein (ADCP) immunoreactivity in colorectal adenocarcinoma. International journal of cancer: Journal international du cancer, vol.37, no.4, 479-485.
Blanco-Prieto, Sonia, De Chiara, Loretta, Rodríguez-Girondo, Mar, Vázquez-Iglesias, Lorena, Rodríguez-Berrocal, Francisco Javier, Fernández-Villar, Alberto, Botana-Rial, María Isabel, de la Cadena, María Páez. Highly Sensitive Marker Panel for Guidance in Lung Cancer Rapid Diagnostic Units. Scientific reports, vol.7, 41151-.
Cordero, Oscar J, Imbernon, Monica, Chiara, Loretta De, Martinez-Zorzano, Vicenta S, Ayude, Daniel, de la Cadena, Maria Paez, Rodriguez-Berrocal, F Javier. Potential of soluble CD26 as a serum marker for colorectal cancer detection.. World journal of clinical oncology, vol.2, no.6, 245-261.
Otero-Estévez, O, De Chiara, L, Rodríguez-Berrocal, F J, de la Cadena, M Páez, Cubiella, J, Castro, I, Gonzalez-Mao, C, Hernandez, V, Martínez-Zorzano, V S. Serum sCD26 for colorectal cancer screening in family-risk individuals: comparison with faecal immunochemical test. The British journal of cancer, vol.112, no.2, 375-381.
De Chiara, Loretta, Rodríguez-Piñeiro, Ana M., Cordero, Oscar J., Vázquez-Tuñas, Lidia, Ayude, Daniel, Rodríguez-Berrocal, Francisco J., de la Cadena, María Páez. Postoperative Serum Levels of sCD26 for Surveillance in Colorectal Cancer Patients. PloS one, vol.9, no.9, e107470-.
Eric-Nikolic, A., Matic, I.Z., @?ordevic, M., Milovanovic, Z., Markovic, I., Dzodic, R., Inic, M., Srdic-Rajic, T., Jevric, M., Gavrilovic, D., Cordero, O.J., Juranic, Z.D.. Serum DPPIV activity and CD26 expression on lymphocytes in patients with benign or malignant breast tumors. Immunobiology, vol.216, no.8, 942-946.
Matić, Ivana Z, Đorđić, Marija, Grozdanić, Nađa, Damjanović, Ana, Kolundžija, Branka, Erić-Nikolić, Aleksandra, Džodić, Radan, Šašić, Miomir, Nikolić, Srđan, Dobrosavljević, Danijela, Rašković, Sanvila, Andrejević, Slađana, Gavrilović, Dušica, Cordero, Oscar J, Juranić, Zorica D. Serum activity of DPPIV and its expression on lymphocytes in patients with melanoma and in people with vitiligo. BMC immunology, vol.13, no.1, 48-48.
Ye, Chunxiang, Tian, Xiuyun, Yue, Guanjun, Yan, Liang, Guan, Xiaoya, Wang, Shan, Hao, Chunyi. Suppression of CD26 inhibits growth and metastasis of pancreatic cancer. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, vol.37, no.12, 15677-15686.
Chang, Jer-Hwa, Cheng, Chao-Wen, Yang, Yi-Chieh, Chen, Wan-Shen, Hung, Wen-Yueh, Chow, Jyh-Ming, Chen, Pai-Sheng, Hsiao, Michael, Lee, Wei-Jiunn, Chien, Ming-Hsien. Downregulating CD26/DPPIV by apigenin modulates the interplay between Akt and Snail/Slug signaling to restrain metastasis of lung cancer with multiple EGFR statuses. Journal of experimental & clinical cancer research, vol.37, no.1, 199-.
Angevin, Eric, Isambert, Nicolas, Trillet-Lenoir, Véronique, You, Benoit, Alexandre, Jérôme, Zalcman, Gérard, Vielh, Philippe, Farace, Françoise, Valleix, Fanny, Podoll, Thomas, Kuramochi, Yu, Miyashita, Itaru, Hosono, Osamu, Dang, Nam H, Ohnuma, Kei, Yamada, Taketo, Kaneko, Yutaro, Morimoto, Chikao. First-in-human phase 1 of YS110, a monoclonal antibody directed against CD26 in advanced CD26-expressing cancers. The British journal of cancer, vol.116, no.9, 1126-1134.
Moreno, Estefanía, Canet, Júlia, Gracia, Eduard, Lluís, Carme, Mallol, Josefa, Canela, Enric I., Cortés, Antoni, Casadó, Vicent. Molecular Evidence of Adenosine Deaminase Linking Adenosine A 2A Receptor and CD26 Proteins. Frontiers in pharmacology, vol.9, 106-.
Tan, E.Y., Mujoomdar, M., Blay, J.. Adenosine Down-Regulates the Surface Expression of Dipeptidyl Peptidase IV on HT-29 Human Colorectal Carcinoma Cells. The American journal of pathology, vol.165, no.1, 319-330.
Mortier, Anneleen, Gouwy, Mieke, Van Damme, Jo, Proost, Paul, Struyf, Sofie. CD26/dipeptidylpeptidase IV—chemokine interactions: double-edged regulation of inflammation and tumor biology. Journal of leukocyte biology, vol.99, no.6, 955-969.
Nargis, Titli, Chakrabarti, Partha. Significance of circulatory DPP4 activity in metabolic diseases. IUBMB life, vol.70, no.2, 112-119.
Jang, Jae-Hwi, Baerts, Lesley, Waumans, Yannick, De Meester, Ingrid, Yamada, Yoshito, Limani, Perparim, Gil-Bazo, Ignacio, Weder, Walter, Jungraithmayr, Wolfgang. Suppression of lung metastases by the CD26/DPP4 inhibitor Vildagliptin in mice. Clinical & experimental metastasis, vol.32, no.7, 677-687.
Femia, Angelo Pietro, Raimondi, Laura, Maglieri, Giulia, Lodovici, Maura, Mannucci, Edoardo, Caderni, Giovanna. Long‐term treatment with Sitagliptin, a dipeptidyl peptidase‐4 inhibitor, reduces colon carcinogenesis and reactive oxygen species in 1,2‐dimethylhydrazine‐induced rats. International journal of cancer: Journal international du cancer, vol.133, no.10, 2498-2503.
YORIFUJI, NAOKI, INOUE, TAKUYA, IGUCHI, MUNETAKA, FUJIWARA, KAORI, KAKIMOTO, KAZUKI, NOUDA, SADAHARU, OKADA, TOSHIHIKO, KAWAKAMI, KEN, ABE, YOSUKE, TAKEUCHI, TOSHIHISA, HIGUCHI, KAZUHIDE. The dipeptidyl peptidase-4 inhibitor sitagliptin suppresses mouse colon tumorigenesis in type 2 diabetic mice. Oncology reports, vol.35, no.2, 676-682.
Mol Clin Oncol Ali A 118 10 2019 A multi‐center retrospective analysisof the effect of DPP4 inhibitors on progression‐free survival in advanced airway and colorectal cancers
Beckenkamp, Aline, Willig, Júlia Biz, Santana, Danielle Bertodo, Nascimento, Jéssica, Paccez, Juliano Domiraci, Zerbini, Luiz Fernando, Bruno, Alessandra Nejar, Pilger, Diogo André, Wink, Márcia Rosângela, Buffon, Andréia. Differential Expression and Enzymatic Activity of DPPIV/CD26 Affects Migration Ability of Cervical Carcinoma Cells. PloS one, vol.10, no.7, e0134305-.
Chei, Sungwoo, Oh, Hyun-Ji, Song, Ji-Hyeon, Seo, Young-Jin, Lee, Kippeum, Lee, Boo-Yong. Magnolol Suppresses TGF-β-Induced Epithelial-to-Mesenchymal Transition in Human Colorectal Cancer Cells. Frontiers in oncology, vol.9, 752-.
Zhu, Shi Mao, Park, Yong Ran, Seo, Seung Yong, Kim, In Hee, Lee, Soo Teik, Kim, Sang Wook. Parthenolide inhibits transforming growth factor β1-induced epithelial-mesenchymal transition in colorectal cancer cells. Intestinal research, vol.17, no.4, 527-536.
Sánchez-Otero, Nuria, Rodríguez-Berrocal, Francisco Javier, de la Cadena, María Páez, Botana-Rial, María Isabel, Cordero, Oscar J.. Evaluation of pleural effusion sCD26 and DPP-IV as diagnostic biomarkers in lung disease. Scientific reports, vol.4, 3999-.
Dehruyne, D., Boterberg, T., Bracke, M.E.. Cell Aggregation Assays. Methods in molecular biology, vol.1070, 77-92.
Henriksson, Maria L., Edin, Sofia, Dahlin, Anna M., Oldenborg, Per-Arne, Öberg, Åke, Van Guelpen, Bethany, Rutegård, Jörgen, Stenling, Roger, Palmqvist, Richard. Colorectal Cancer Cells Activate Adjacent Fibroblasts Resulting in FGF1/FGFR3 Signaling and Increased Invasion. The American journal of pathology, vol.178, no.3, 1387-1394.
Hanski, C., Huhle, T., Gossrau, R., Reutter, W.. Direct evidence for the binding of rat liver DPP IV to collagen in vitro. Experimental cell research, vol.178, no.1, 64-72.
Piazza, G A, Callanan, H M, Mowery, J, Hixson, D C. Evidence for a role of dipeptidyl peptidase IV in fibronectin-mediated interactions of hepatocytes with extracellular matrix. The Biochemical journal, vol.262, no.1, 327-334.
Okamoto, Toshihiro, Iwata, Satoshi, Yamazaki, Hiroto, Hatano, Ryo, Komiya, Eriko, Dang, Nam H., Ohnuma, Kei, Morimoto, Chikao. CD9 Negatively Regulates CD26 Expression and Inhibits CD26-Mediated Enhancement of Invasive Potential of Malignant Mesothelioma Cells. PloS one, vol.9, no.1, e86671-.
Cheng, Hung-Chi, Abdel-Ghany, Mossaad, Pauli, Bendicht U.. A Novel Consensus Motif in Fibronectin Mediates Dipeptidyl Peptidase IV Adhesion and Metastasis. The Journal of biological chemistry, vol.278, no.27, 24600-24607.
Loster, K., Zeilinger, K., Schuppan, D., Reutter, W.. The Cysteine-Rich Region of Dipeptidyl Peptidase IV (CD 26) Is the Collagen Binding Site. Biochemical and biophysical research communications, vol.217, no.1, 341-348.
Cancer Res Glinsky VV 3805 63 2003 Intravascular metastatic cancer cell homotypic aggregation at the sites of primary attachment to the endothelium
Mayor, Roberto, Etienne-Manneville, Sandrine. The front and rear of collective cell migration. Nature reviews. Molecular cell biology, vol.17, no.2, 97-109.
Bauvois, B. A collagen-binding glycoprotein on the surface of mouse fibroblasts is identified as dipeptidyl peptidase IV. The Biochemical journal, vol.252, no.3, 723-731.
Iwase-Okada, K., Kojima, K., Kato, T., Kaku, H., Okazaki, T., Wago, K., Sakakibara, S., Nagatsu, T.. Collagenase-like peptidase activity in serum from patients with rheumatoid arthritis. Experientia, vol.41, no.4, 487-488.
Ghersi, Giulio, Dong, Huan, Goldstein, Leslie A., Yeh, Yunyun, Hakkinen, Lari, Larjava, Hannu S., Chen, Wen-Tien. Regulation of Fibroblast Migration on Collagenous Matrix by a Cell Surface Peptidase Complex. The Journal of biological chemistry, vol.277, no.32, 29231-29241.
ASADA, Y., ARATAKE, Y., KOTANI, T., MARUTSUKA, K., ARAKI, Y., OHTAKI, S., SUMIYOSHI, A.. Expression of dipeptidyl aminopeptidase IV activity in human lung carcinoma. Histopathology, vol.23, no.3, 265-270.
Histol Histopathol Pro B 1345 19 2004 CD26/dipeptidyl peptidase IV and its role in cancer
Liu, Suling, Cong, Yang, Wang, Dong, Sun, Yu, Deng, Lu, Liu, Yajing, Martin-Trevino, Rachel, Shang, Li, McDermott, Sean P., Landis, Melissa D., Hong, Suhyung, Adams, April, D’Angelo, Rosemarie, Ginestier, Christophe, Charafe-Jauffret, Emmanuelle, Clouthier, Shawn G., Birnbaum, Daniel, Wong, Stephen T., Zhan, Ming, Chang, Jenny C., Wicha, Max S.. Breast Cancer Stem Cells Transition between Epithelial and Mesenchymal States Reflective of their Normal Counterparts. Stem cell reports, vol.2, no.1, 78-91.
Abrahami, Devin, Yin, Hui, Yu, Oriana H. Y., Pollak, Michael N., Azoulay, Laurent. Incretin-based Drugs and the Incidence of Colorectal Cancer in Patients with Type 2 Diabetes. Epidemiology, vol.29, no.2, 246-253.
Gallwitz, Baptist. Clinical Use of DPP-4 Inhibitors. Frontiers in Endocrinology, vol.10, 389-.
Yamaguchi, Takehiro, Watanabe, Ayano, Tanaka, Masako, Shiota, Masayuki, Osada-Oka, Mayuko, Sano, Soichi, Yoshiyama, Minoru, Miura, Katsuyuki, Kitajima, Shojiro, Matsunaga, Shinji, Tomita, Shuhei, Iwao, Hiroshi, Izumi, Yasukatsu. A dipeptidyl peptidase-4 (DPP-4) inhibitor, linagliptin, attenuates cardiac dysfunction after myocardial infarction independently of DPP-4. Journal of pharmacological sciences, vol.139, no.2, 112-119.
Li, Yan, Zhang, Julei, Zhou, Qin, Wang, Hongtao, Xie, Songtao, Yang, Xuekang, Ji, Peng, Zhang, Wanfu, He, Ting, Liu, Yang, Wang, Kejia, Li, Xiaoqiang, Shi, Jihong, Hu, Dahai. Linagliptin inhibits high glucose‐induced transdifferentiation of hypertrophic scar‐derived fibroblasts to myofibroblasts via IGF/Akt/mTOR signalling pathway. Experimental dermatology, vol.28, no.1, 19-27.
Bachovchin, Daniel A, Koblan, Luke W, Wu, Wengen, Liu, Yuxin, Li, Youhua, Zhao, Peng, Woznica, Iwona, Shu, Ying, Lai, Jack H, Poplawski, Sarah E, Kiritsy, Christopher P, Healey, Sarah E, DiMare, Matthew, Sanford, David G, Munford, Robert S, Bachovchin, William W, Golub, Todd R. A high-throughput, multiplexed assay for superfamily-wide profiling of enzyme activity. Nature chemical biology, vol.10, no.8, 656-663.
Chui, Ashley J., Okondo, Marian C., Rao, Sahana D., Gai, Kuo, Griswold, Andrew R., Johnson, Darren C., Ball, Daniel P., Taabazuing, Cornelius Y., Orth, Elizabeth L., Vittimberga, Brooke A., Bachovchin, Daniel A.. N-terminal degradation activates the NLRP1B inflammasome. Science, vol.364, no.6435, 82-85.
Zhang, Hui, Chen, Yiqian, Keane, Fiona M., Gorrell, Mark D.. Advances in Understanding the Expression and Function of Dipeptidyl Peptidase 8 and 9. Molecular cancer research, vol.11, no.12, 1487-1496.
Ross, Breyan, Krapp, Stephan, Augustin, Martin, Kierfersauer, Reiner, Arciniega, Marcelino, Geiss-Friedlander, Ruth, Huber, Robert. Structures and mechanism of dipeptidyl peptidases 8 and 9, important players in cellular homeostasis and cancer. Proceedings of the National Academy of Sciences of the United States of America, vol.115, no.7, E1437-E1445.
Yu, Denise M. T., Wang, Xin M., McCaughan, Geoffrey W., Gorrell, Mark D.. Extraenzymatic functions of the dipeptidyl peptidase IV-related proteins DP8 and DP9 in cell adhesion, migration and apoptosis. The FEBS journal, vol.273, no.11, 2447-2460.
Zhang, H., Chen, Y., Wadham, C., McCaughan, G.W., Keane, F.M., Gorrell, M.D.. Dipeptidyl peptidase 9 subcellular localization and a role in cell adhesion involving focal adhesion kinase and paxillin. Biochimica et biophysica acta, Molecular cell research, vol.1853, no.2, 470-480.
Noh, Yoojin, Jeon, Sang‐Min, Shin, Sooyoung. Association between glucose‐lowering treatment and cancer metastasis among patients with preexisting type 2 diabetes and incident malignancy. International journal of cancer: Journal international du cancer, vol.144, no.7, 1530-1539.
Golightly, Larry K., Drayna, Caitlin C., McDermott, Michael T.. Comparative Clinical Pharmacokinetics of Dipeptidyl Peptidase-4 Inhibitors. Clinical pharmacokinetics, vol.51, no.8, 501-514.
Campbell, Timothy, B.. CD26 inhibition and hematopoiesis: a novel approach to enhance transplantation. Frontiers in bioscience, vol.13, no.5, 1795-.
Res Square Kaneko Y Serum soluble CD26/DPP4 titer variation is a potential prognostic biomarker in cancer therapy with a humanized anti‐CD26 antibody
Nauck, Michael A., Meier, Juris J., Cavender, Matthew A., Abd El Aziz, Mirna, Drucker, Daniel J.. Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors. Circulation, vol.136, no.9, 849-870.
Duan, Lihua, Rao, Xiaoquan, Xia, Chang, Rajagopalan, Sanjay, Zhong, Jixin. The regulatory role of DPP4 in atherosclerotic disease. Cardiovascular diabetology, vol.16, 76-.
Ahmed, D, Eide, P W, Eilertsen, I A, Danielsen, S A, Eknæs, M, Hektoen, M, Lind, G E, Lothe, R A. Epigenetic and genetic features of 24 colon cancer cell lines. Oncogenesis, vol.2, e71-.
Cancer Res Leibovitz A 4562 36 1976 Classification of human colorectal adenocarcinoma cell lines
Murakami, H, Masui, H. Hormonal control of human colon carcinoma cell growth in serum-free medium.. Proceedings of the National Academy of Sciences of the United States of America, vol.77, no.6, 3464-3468.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.